Japan's Planimal Cells Could Reshape Biomanufacturing
A Japanese team has created the world's first hybrid plant-animal cells, fusing algal DNA into animal cell chromosomes. Though currently dormant, the breakthrough opens a direct path to photosynthesis-driven drug factories and cultured meat.
The First True Planimal Exists
A team of Japanese researchers has done something no one has accomplished before: they have fused plant and animal cells into a single living organism. The result, which the team calls a “planimal” cell, represents a genuine scientific first and carries implications that stretch well beyond academic curiosity.
The work, published in Nature Communications, comes from a collaboration between the University of Tokyo, the Institute of Science Tokyo, Kindai University, and other institutions led by Sachihiro Matsunaga, a professor at the University of Tokyo’s Graduate School of Frontier Sciences. Matsunaga had proposed the very idea of a planimal as far back as 2018. Nearly six years later, his lab proved it was possible.
How They Did It
The team chose Cyanidioschyzon merolae, a species of red alga that lives in hot springs and acidic environments — conditions most animals would find instantly lethal. What makes C. merolae particularly suited for this experiment is that it lacks a rigid cell wall, a feature that normally blocks fusion between plant and animal cells. Its genome is also exceptionally small, making genetic integration more manageable.
Using a conventional method involving polyethylene glycol, the researchers pushed the alga into cultured Chinese hamster ovary (CHO) cells — the same cell line used globally to produce therapeutic proteins and biologics. The fusion rate was low, but the team succeeded in creating hybrid cells in which every strand of C. merolae DNA became integrated into the animal cell’s own chromosomes.
This is the critical detail that separates this achievement from earlier partial mergers or temporary co-cultures. The algal genome wasn’t just present alongside the animal DNA; it was woven into the cell’s inherited material.
Why the Plants Stayed Quiet
Here’s where the science gets honest — and interesting. In the current version of these planimals, the integrated plant DNA is effectively switched off. A process called methylation acts as a molecular silencer, freezing the algal genes in place. The chloroplasts, the organelles responsible for photosynthesis, were degraded during the fusion process.
In practical terms, the planimal cells function exactly like ordinary CHO cells: they divide, multiply, and pass on their genetics across more than 150 generations. But they do not photosynthesize. They do not use the plant genes to produce anything new. Right now, they are animal cells wearing algal code they can’t read.
That changes everything if the team can flip those switches on.
What Happens Next If the Genes Wake Up
Matsunaga’s stated goal is precise: activate the C. merolae genes and reintroduce functional chloroplasts so the hybrid cells can generate oxygen through photosynthesis. If that happens, the biological consequences are significant.
Photosynthesis converts light, water, and carbon dioxide into chemical energy. In a traditional bioreactor, that energy comes from expensive nutrient media — glucose, amino acids, growth factors — purchased, sterilized, and waste-managed at industrial scale. A photosynthetic planimal cell would partially power itself using sunlight. The cost structure of cellular biomanufacturing shifts dramatically when you replace a portion of your input costs with free solar energy and ambient CO₂.
This is not theoretical speculation. The planimal cells already exist. They are stable. They replicate. The only remaining barrier is functional activation of the plant genome and chloroplast machinery.
Who Wins and Who Loses
If Matsunaga’s team and others can commercialize photosynthetic hybrid cells, several industries face reconfiguration.
Pharmaceuticals win first. CHO cells are the workhorses of biologic drug production — antibodies, vaccines, enzyme therapies. Currently, keeping billions of these cells fed and happy in steel tanks accounts for a substantial share of manufacturing overhead. A photosynthetic variant would lower operating costs, reduce dependency on imported fermentation media, and open the door to outdoor or semi-outdoor bioproduction that is impossible with conventional cell lines.
Cultured meat follows. The economics of lab-grown protein hinge on the price of cell culture medium, which remains prohibitively expensive at scale. Any approach that reduces that input cost by letting cells generate part of their own energy from light is directly relevant to the cultured protein industry. Planimals could, in principle, be engineered toward that application.
Traditional agriculture isn’t threatened — yet. These are single-cell organisms, not crops. The timeline from laboratory proof-of-concept to agricultural disruption is measured in decades, if it arrives at all.
Environmental groups should watch closely. A photosynthetic organism that escapes containment and enters natural ecosystems introduces unknown variables. The C. merolae alga itself is a extremophile adapted to harsh conditions, which could make it surprisingly resilient if released. Containment protocols for planimal facilities would need to be rigorous.
What English-Language Readers Miss
International coverage of Japanese science often treats results as isolated achievements rather than nodes in a broader ecosystem. This paper sits within a longer Japanese trajectory in synthetic biology and cell engineering that includes foundational work on extremophile genomes, advanced cell fusion techniques, and state-backed investment in next-generation biomanufacturing. The University of Tokyo’s involvement signals institutional priority, not opportunistic publishing.
Japan also faces structural pressures that make this kind of innovation strategically important. An aging population, declining agricultural labor, and heavy reliance on imported biopharma feedstocks create economic incentives that Western countries feel less acutely. Planimal cells are not just science for science’s sake in this context; they are infrastructure thinking disguised as biology.
The Hard Part Ahead
Getting the genes to express is only the beginning. Even if chloroplasts are reconstituted and photosynthesis activates, the hybrid cell must balance two fundamentally different metabolic programs — one evolved over a billion years in plants, another in animals — inside the same membrane. Energy allocation, waste management, protein folding, signaling pathways: each system will need re-tuning. The 150+ generations of stable replication the team has already observed is encouraging, but stability under dark laboratory conditions is a different challenge from sustained productivity under light-driven metabolism.
None of this means the result is insignificant. It means the milestone is real, the foundation is laid, and the hard engineering work starts now.
What exists today is a living proof of concept: a cell that carries both plant and animal genetic blueprints and divides faithfully. What comes next depends on whether anyone can teach that second blueprint to speak.